首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3280119篇
  免费   265625篇
  国内免费   9538篇
耳鼻咽喉   46449篇
儿科学   102928篇
妇产科学   88063篇
基础医学   457016篇
口腔科学   95279篇
临床医学   298536篇
内科学   651907篇
皮肤病学   72285篇
神经病学   275568篇
特种医学   130384篇
外国民族医学   1111篇
外科学   498040篇
综合类   77328篇
现状与发展   3篇
一般理论   1322篇
预防医学   270275篇
眼科学   75032篇
药学   239074篇
  9篇
中国医学   6154篇
肿瘤学   168519篇
  2018年   36391篇
  2017年   27614篇
  2016年   31051篇
  2015年   34985篇
  2014年   49188篇
  2013年   74606篇
  2012年   98687篇
  2011年   105053篇
  2010年   62645篇
  2009年   59457篇
  2008年   98041篇
  2007年   104233篇
  2006年   104871篇
  2005年   102155篇
  2004年   97631篇
  2003年   94245篇
  2002年   91589篇
  2001年   148327篇
  2000年   153505篇
  1999年   129095篇
  1998年   38799篇
  1997年   34974篇
  1996年   35270篇
  1995年   34714篇
  1994年   32528篇
  1993年   30450篇
  1992年   105227篇
  1991年   101949篇
  1990年   98346篇
  1989年   94186篇
  1988年   87615篇
  1987年   86441篇
  1986年   81833篇
  1985年   78628篇
  1984年   59917篇
  1983年   51051篇
  1982年   31557篇
  1981年   28379篇
  1980年   26712篇
  1979年   55809篇
  1978年   39890篇
  1977年   33611篇
  1976年   31422篇
  1975年   32999篇
  1974年   40211篇
  1973年   38336篇
  1972年   35824篇
  1971年   33216篇
  1970年   31047篇
  1969年   28907篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
61.
62.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
63.
64.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
65.
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development.  相似文献   
66.
67.
68.
69.
70.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号